Moderna will increase minimal 2021 Covid vaccine manufacturing by 20% to 600 million doses
A medical worker holds a Moderna COVID-19 vaccine vial on the first day that Orange County residents 65 and older are able to be vaccinated at a drive through site at the Orange County Convention Center on December 29, 2020 in Orlando, Florida.
Paul Hennessy | NurPhoto | Getty Images
Moderna is increasing its Covid-19 vaccine production this year, upping the minimum number of doses it expects to make by 20% to 600 million, the company announced Monday.
The company said it’s working to produce up to 1 billion doses of its Covid-19 vaccine this year. The U.S. is on track to secure 100 million doses of Moderna’s vaccine by the end of March and additional 100 million by June, the Massachusetts-based company said in a statement.
The U.S. Food and Drug Administration granted Moderna’s Covid-19 vaccine emergency authorization for people 18 and older the United States in December and has started the drug’s initial roll-out.
The federal government has agreed to buy 200 million doses of Moderna’s vaccine with the option to secure an additional 300 million doses, the company said.
This is a developing story. Please check back later for updates.